MDT

97.73

+1.69%↑

A

145.49

-1.42%↓

VEEV

220.23

-3.16%↓

HQY

83.75

+0.5%↑

NEOG

9.26

+0.54%↑

MDT

97.73

+1.69%↑

A

145.49

-1.42%↓

VEEV

220.23

-3.16%↓

HQY

83.75

+0.5%↑

NEOG

9.26

+0.54%↑

MDT

97.73

+1.69%↑

A

145.49

-1.42%↓

VEEV

220.23

-3.16%↓

HQY

83.75

+0.5%↑

NEOG

9.26

+0.54%↑

MDT

97.73

+1.69%↑

A

145.49

-1.42%↓

VEEV

220.23

-3.16%↓

HQY

83.75

+0.5%↑

NEOG

9.26

+0.54%↑

MDT

97.73

+1.69%↑

A

145.49

-1.42%↓

VEEV

220.23

-3.16%↓

HQY

83.75

+0.5%↑

NEOG

9.26

+0.54%↑

Search

Cencora Inc

Open

SectorHealthcare

350.11 1.16

Overview

Share price change

24h

Current

Min

345.94

Max

350.8

Key metrics

By Trading Economics

Income

-1B

-340M

Sales

3.1B

84B

P/E

Sector Avg

42.931

90.831

EPS

3.84

Dividend yield

0.66

Profit margin

-0.406

Employees

47,000

EBITDA

-1.1B

150M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+15.73% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.66%

2.20%

Next Earnings

4 Feb 2026

Next Dividend date

2 Mar 2026

Next Ex Dividend date

13 Feb 2026

Market Stats

By TradingEconomics

Market Cap

278M

66B

Previous open

348.95

Previous close

350.11

News Sentiment

By Acuity

17%

83%

13 / 361 Healthcare

Cencora Inc Chart

Past performance is not a reliable indicator of future results.

Related News

14 Jan 2026, 22:41 UTC

Acquisitions, Mergers, Takeovers

Canadian Natural Resources, Tourmaline File Deal Notice With Antitrust Regulator

15 Jan 2026, 00:00 UTC

Earnings

Welcome to Greenland, an Economy Reliant on Subsidies and Shrimp -- WSJ

14 Jan 2026, 23:47 UTC

Market Talk

Oil Slips After Trump Appears to Tilt Away From Military Action in Iran -- Market Talk

14 Jan 2026, 23:44 UTC

Market Talk

Nikkei May Decline After Hitting Record Highs; Election in Focus -- Market Talk

14 Jan 2026, 23:39 UTC

Market Talk

ANZ's New Bull Still Sees Valuation Gap to Peers -- Market Talk

14 Jan 2026, 23:32 UTC

Market Talk

Gold Declines on Likely Technical Correction, Possible Profit-Taking -- Market Talk

14 Jan 2026, 22:56 UTC

Acquisitions, Mergers, Takeovers

Soho House Amends Rollover and Support Agreements With Broad Street Principal Investments and Others

14 Jan 2026, 22:53 UTC

Acquisitions, Mergers, Takeovers

Soho House: Apollo Global Management and Goldman Sachs Asset Management Amend Debt Commitment

14 Jan 2026, 22:17 UTC

Market Talk

Global Equities Roundup: Market Talk

14 Jan 2026, 22:17 UTC

Market Talk

WiseTech's Revenue Growth Drivers Attract Scrutiny -- Market Talk

14 Jan 2026, 22:09 UTC

Earnings

CITIC Securities: Uptrend in China Capital Markets Supported Results >600030.SH

14 Jan 2026, 22:08 UTC

Earnings

CITIC Securities 2025 Oper Rev CNY74.83B Vs. CNY58.12B >600030.SH

14 Jan 2026, 22:08 UTC

Earnings

CITIC Securities 2025 Net CNY30.05B Vs. Net CNY21.57B >600030.SH

14 Jan 2026, 21:53 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Expects 2025 Net to Increase Over 38% on Year

14 Jan 2026, 21:53 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Expects 2025 Revenue to Increase More Than 45% on Year

14 Jan 2026, 21:52 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Announces Positive Profit Alert for 2025

14 Jan 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

Citigroup Acting as Financial Advisor to WuXi XDC

14 Jan 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC: Aims to Keep Listing Status of BioDlink

14 Jan 2026, 21:51 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC: Company to Finance BioDlink Shares Acquisition via Internal Resources

14 Jan 2026, 21:50 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

14 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

14 Jan 2026, 21:49 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC: BioDlink Offer to Cost HK$2.79B

14 Jan 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Offers to Pay HK$4.00 for Each BioDlink International Share

14 Jan 2026, 21:48 UTC

Acquisitions, Mergers, Takeovers

WuXi XDC Makes Cash Offer for BioDlink International

14 Jan 2026, 21:13 UTC

Market Talk

Oil Retreats Late After Trump Comments on Iran -- Market Talk

14 Jan 2026, 20:30 UTC

Market Talk
Earnings

Danaher's Preliminary 4Q Seen as Promising -- Market Talk

14 Jan 2026, 20:13 UTC

Market Talk

U.S. Natural Gas Futures Sink Ahead of Storage Report -- Market Talk

14 Jan 2026, 20:08 UTC

Market Talk

Oil Futures Extend Rally on Iran Tensions -- Market Talk

14 Jan 2026, 19:33 UTC

Market Talk

Nutrien Seen as Winner in Tighter 2026 Potash Market, Higher Prices -- Market Talk

14 Jan 2026, 19:06 UTC

Market Talk
Earnings

Wells Fargo Says Customers, Economy Remain Resilient -- Market Talk

Peer Comparison

Price change

Cencora Inc Forecast

Price Target

By TipRanks

15.73% upside

12 Months Forecast

Average 400.3 USD  15.73%

High 440 USD

Low 360 USD

Based on 10 Wall Street analysts offering 12 month price targets forCencora Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

10 ratings

9

Buy

1

Hold

0

Sell

Sentiment

By Acuity

13 / 361 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Cencora Inc

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat